H-Val-Pro-Pro-OH
目录号 : GC31529
H-Val-Pro-Pro-OH是一种乳源活性三肽，可抑制血管紧张素转换酶(ACE)活性，IC50值为9μM。
Cas No.:58872-39-2
Sample solution is provided at 25 µL, 10mM.
H-Val-Pro-Pro-OH is a milk-derived tripeptide that inhibits Angiotensin I converting enzyme (ACE), with an IC50 of 9μM[1]. H-Val-Pro-Pro-OH can stimulate insulin signaling, especially phosphorylation of protein kinase B and insulin receptor (IR), to ameliorate insulin resistant[2]. H-Val-Pro-Pro-OH has been widely used in different animal models to regulate immune function and inhibit inflammatory responses[3].
In vitro, H-Val-Pro-Pro-OH pretreatment (50μM) for 12 hours can significantly inhibit the proliferation of vascular smooth muscle cells (VSMCs) induced by angiotensin II (Ang II)[4]. Treatment with 600μM H-Val-Pro-Pro-OH for 18 hours significantly enhanced glucose consumption in HepG2 cells, regulated the activity of glucose metabolism enzymes, and increased the protein levels of phosphorylated AKT (p-AKT) and GLUT2 in HepG2 cells[5]. Treatment with H-Val-Pro-Pro-OH (50μM) for 72 hours significantly increased lipid accumulation in 3T3-F442A cells, leading to a significant increase in PPARγ and adiponectin expression[6].
In vivo, H-Val-Pro-Pro-OH treatment via oral administration at a dose of 30mg/kg/day for 8 weeks alleviated the left ventricular hypertrophy, abnormal glomerular morphology and thickening of small arteries in the kidneys caused by N(G)-nitro-L-arginine methyl ester hydrochloride (L-NAME) in rats[7]. Oral administration of 125.4μmol/kg/day of H-Val-Pro-Pro-OH daily for 31 consecutive weeks delayed the development of atherosclerosis in male apoE(-/-) mice and reduced the expression of inflammatory factors[8].
References:
[1] Nakamura Y, Yamamoto N, Sakai K, et al. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk[J]. Journal of dairy science, 1995, 78(4): 777-783.
[2] Li S, Bu T, Zheng J, et al. Preparation, bioavailability, and mechanism of emerging activities of Ile‐Pro‐Pro and Val‐Pro‐Pro[J]. Comprehensive Reviews in Food Science and Food Safety, 2019, 18(4): 1097-1110.
[3] Pérez-Vielma N M, Gómez-López M, Maldonado J, et al. Recognition of the interaction between the bioactive peptide Val–Pro–Pro and the minimal promoter region of genes SOD and CAT using QCM-D and docking studies[J]. Analytical Methods, 2023, 15(24): 2979-2988.
[4] Song T, Lv M, Sun B, et al. Tripeptides Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP) regulate the proliferation and migration of vascular Smooth muscle cells by interfering Ang II-induced human umbilical vein endothelial cells derived EVs delivering RNAs to VSMCs in the co-culture model[J]. Journal of agricultural and food chemistry, 2020, 68(24): 6628-6637.
[5] Wang C, Zheng L, Zhao M. Molecular targets and mechanisms of casein-derived tripeptides Ile-Pro-Pro and Val-Pro-Pro on hepatic glucose metabolism[J]. Journal of Agricultural and Food Chemistry, 2023, 71(48): 18802-18814.
[6] Chakrabarti S, Wu J. Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) promote adipocyte differentiation and inhibit inflammation in 3T3-F442A cells[J]. PloS one, 2015, 10(2): e0117492.
[7] Nonaka A, Nakamura T, Hirota T, et al. The milk-derived peptides Val-Pro-Pro and Ile-Pro-Pro attenuate arterial dysfunction in L-NAME-treated rats[J]. Hypertension Research, 2014, 37(8): 703-707.
[8] Nakamura T, Hirota T, Mizushima K, et al. Milk-derived peptides, Val-Pro-Pro and Ile-Pro-Pro, attenuate atherosclerosis development in apolipoprotein E–deficient mice: a preliminary study[J]. Journal of medicinal food, 2013, 16(5): 396-403.
H-Val-Pro-Pro-OH是一种乳源活性三肽，可抑制血管紧张素转换酶(ACE)活性，IC50值为9μM[1]。H-Val-Pro-Pro-OH通过刺激胰岛素信号通路，增强蛋白激酶B磷酸化及胰岛素受体活化，从而改善胰岛素抵抗[2]，H-Val-Pro-Pro-OH已广泛应用于不同动物模型中调节免疫功能及抑制炎症反应[3]。
在体外，使用50μM的H-Val-Pro-Pro-OH预处理血管平滑肌细胞(VSMCs)12小时，能显著抑制血管紧张素II(Ang II)诱导的细胞增殖[4]。用600μM的H-Val-Pro-Pro-OH处理HepG2细胞18小时，可显著增强葡萄糖消耗量，调节糖代谢酶活性，并提高磷酸化AKT和GLUT2蛋白水平[5]。以50μM的H-Val-Pro-Pro-OH处理3T3-F442A细胞72小时，能显著促进脂质积累，同时增加PPARγ和脂联素表达[6]。
在体内，每日口服30mg/kg/day剂量的H-Val-Pro-Pro-OH连续8周，可缓解N(G)-nitro-L-arginine methyl ester hydrochloride (L-NAME)诱导的大鼠左心室肥厚、肾小球形态异常及肾小动脉增厚[7]。连续31周每日口服125.4μmol/kg剂量的H-Val-Pro-Pro-OH，能延缓雄性apoE(-/-)小鼠的动脉粥样硬化进展，并降低炎症因子表达水平[8]。
| Cell experiment [1]: | |
Cell lines | HepG2 cells |
Preparation Method | HepG2 cells were cultured in a minimal essential medium (MEM) supplemented with 10% fetal bovine serum, 100μg/ml streptomycin, 100U/ml penicillin and 1% pyruvate sodium, under a humidified environment of 37°C and 5% CO2. HepG2 cells were seeded at a density of 1×105 cells per well in a 96-well plate. After incubation for 24 hours, the culture medium was discarded. Then, the cells were treated with H-Val-Pro-Pro-OH (600μM) in the presence of 10mM glucose for 18 hours, and the glucose metabolism enzymes and glucose consumption were measured. |
Reaction Conditions | 600μM; 18h |
Applications | H-Val-Pro-Pro-OH significantly increased the glucose consumption of HepG2 cells and reduced the activity of Phosphoenolpyruvate carboxykinase. |
| Animal experiment [2]: | |
Animal models | Male Wistar rat |
Preparation Method | 7-week-old male Wistar rats were acclimated for 1 week in a room with controlled temperature (23℃), humidity (55%), and lighting (12:12 hours light-dark cycle), and rats were allowed to freely access food and tap water. Based on the body weight, the rats were randomly divided into 3 groups. The first group (control group) drank untreated drinking water. The second group (L-NAME group) drank L-NAME dissolved in the drinking water (1g/l, 100mg/kg/day). The third group (L-NAME + VPP group) drank L-NAME (1g/l) and H-Val-Pro-Pro-OH (0.3g/l, 30mg/kg/day), for a duration of 8 weeks. The hearts and kidneys of the rats were collected for histopathological analysis. |
Dosage form | 30mg/kg/day for 8 weeks; p.o. |
Applications | H-Val-Pro-Pro-OH treatment alleviated the left ventricular hypertrophy, abnormal glomerular morphology and thickening of small arteries in the kidneys caused by L-NAME in rats. |
References: | |
| Cas No. | 58872-39-2 | SDF | |
| 分子式 | C15H25N3O4 | 分子量 | 311.38 |
| 溶解度 | 125 mg/mL in Water(Need ultrasonic) | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.2115 mL | 16.0576 mL | 32.1151 mL |
| 5 mM | 642.3 μL | 3.2115 mL | 6.423 mL |
| 10 mM | 321.2 μL | 1.6058 mL | 3.2115 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet